TP53 and colorectal carcinoma: On the other hand, TP53 mutations appear early in IBD-associated CRC, contrasting with the later occurrence of these mutations in sporadic CRC, suggesting that alternative mechanisms drive tumorigenesis in colitis-associated cancer [16].